Association of +1245 a/G MT1A and -209 a/G MT2A Polymorphysms With Coronary Artery Disease and Diabetes Mellitus in Bulgarian Cohort

Biotechnology and Biotechnological Equipment - United Kingdom
doi 10.5504/50yrtimb.2011.0019
Full Text
Abstract

Available in full text

Categories
Biotechnology
Date
Authors
Publisher

Informa UK Limited

Related search

Coronary Artery Disease and Diabetes Mellitus

Heart Failure Clinics
MedicineCardiovascular MedicineCardiology
2016English

MT1A (A>G), MT1A (C>G), MT1M (A>C) and MT4 (G>A) Single Nucleotide Polymorphism Allele Frequencies in Iranian Populations

Biotechnology and Biotechnological Equipment
Biotechnology
2016English

G(-30)A Polymorphism in the Pancreatic Promoter of the Glucokinase Gene Associated With Angiographic Coronary Artery Disease and Type 2 Diabetes Mellitus

Circulation
Cardiovascular MedicinePhysiologyCardiology
2004English

Multivessel Coronary Artery Disease in Diabetes Mellitus Patients

Kurdistan Journal of Applied Research
2019English

Distribution of Coronary Artery Disease in Acute Coronary Syndrome Patients With Diabetes Mellitus

Journal of Cardiothoracic Surgery
CardiologyCardiovascular MedicineMedicinePulmonaryRespiratory MedicineSurgery
2013English

Association Between Hepato-Biliary Status and HbA1C in Type 2 Diabetes Mellitus With Coronary Artery Disease (CAD)

Journal of Diabetes Mellitus
2015English

E0111 Association Between Myeloperoxidase -463 G/a Gene Polymorphism and Its Plasma Levels With Risk of Coronary Artery Disease in Chinese Population

Heart
Cardiovascular MedicineCardiology
2010English

Potential Impact of COMT-rs4680 G > a Gene Polymorphism in Coronary Artery Disease

Journal of Cardiovascular Development and Disease
2018English

Relationship Between Coronary Artery Disease and Retinopathy in Patients With Type 2 Diabetes Mellitus

Internal Medicine
Internal MedicineMedicine
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy